These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Treatment of acute Graves orbitopathy. Kazim M; Trokel S; Moore S Ophthalmology; 1991 Sep; 98(9):1443-8. PubMed ID: 1945322 [TBL] [Abstract][Full Text] [Related]
50. [Management of Graves' ophthalmopathy]. Schalin-Jäntti C Duodecim; 2010; 126(20):2431-7. PubMed ID: 21125757 [TBL] [Abstract][Full Text] [Related]
51. Combined radiotherapy and medical immunosuppression in the management of thyroid eye disease. Claridge KG; Ghabrial R; Davis G; Tomlinson M; Goodman S; Harrad RA; Potts MJ Eye (Lond); 1997; 11 ( Pt 5)():717-22. PubMed ID: 9474324 [TBL] [Abstract][Full Text] [Related]
52. Teprotumumab: A Review in Thyroid Eye Disease. Nie T; Lamb YN Drugs; 2022 Nov; 82(17):1663-1670. PubMed ID: 36418673 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease. Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822 [TBL] [Abstract][Full Text] [Related]
54. Management of patients in a combined thyroid eye clinic in secondary care. Benzimra JD; Quinn AG; Kersey T; McGrane D; Goss L; Vaidya B Int Ophthalmol; 2014 Feb; 34(1):1-6. PubMed ID: 23549634 [TBL] [Abstract][Full Text] [Related]
55. [Results of 3-stage treatment: (I) corticotherapy, (II) linear acceleration and (III) orbital decompression in 206 patients with malignant Graves ophthalmopathy]. Zgliczyński S; Jastrzebska H; Górowski T; Janik J; Kuś J; Hliniak A; Karczmarzyk R; Kukołowicz P Endokrynol Pol; 1992; 43(3):274-86. PubMed ID: 1345567 [TBL] [Abstract][Full Text] [Related]
56. Thyroid eye disease: what is new to know? Li Z; Cestari DM; Fortin E Curr Opin Ophthalmol; 2018 Nov; 29(6):528-534. PubMed ID: 30124533 [TBL] [Abstract][Full Text] [Related]
57. Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review. Ismailova DS; Belovalova IM; Grusha YO; Sviridenko NY Int Med Case Rep J; 2018; 11():243-249. PubMed ID: 30319289 [TBL] [Abstract][Full Text] [Related]
58. Variation in the use of definitive treatment options in the management of Graves' disease: a UK clinician survey. Hookham J; Collins EE; Allahabadia A; Balasubramanian SP Postgrad Med J; 2017 Apr; 93(1098):198-204. PubMed ID: 27531964 [TBL] [Abstract][Full Text] [Related]
59. Acute and Recurrent Pericarditis. Imazio M; Gaita F Cardiol Clin; 2017 Nov; 35(4):505-513. PubMed ID: 29025542 [TBL] [Abstract][Full Text] [Related]
60. Management of Graves' ophthalmopathy: reality and perspectives. Bartalena L; Pinchera A; Marcocci C Endocr Rev; 2000 Apr; 21(2):168-99. PubMed ID: 10782363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]